Running and a long life

02apr20 04mar20

participation in running, regardless of its dose, would probably lead to

substantial improvements in

     population health and    

     longevity.

Any amount of running, even just once a week, is better than no running,

but higher doses of running may not necessarily be associated with greater mortality benefits.

Fourteen studies from six prospective cohorts with a pooled sample of 232 149 participants were included. In total, 25 951 deaths were recorded during 5.5–35 year follow-ups. Our meta-analysis showed that

running participation is associated with

27%, 30% and 23% lower risk of

     all-cause,

     cardiovascular and

     cancer mortality, respectively,

                         compared with no running.

A meta-regression analysis showed no significant dose–response trends for weekly frequency, weekly duration, pace and the total volume of running.

https://bjsm.bmj.com/content/early/2019/09/25/bjsports-2018-100493